Silence Therapeutics Stock Surges 125% to $19.58 on Merck KGaA $20 Per Share Cash Bid
According to Nasdaq and SEC filings, Silence Therapeutics stock closed at $19.58 on Monday, October 19, up 125.58% from Friday's $8.68, after Merck KGaA, Darmstadt, Germany announced a $20 per American depositary share cash acquisition. The deal values the biotechnology company at
NDAQ+0.65%
GateNews·10-20 13:31
